established bone metastases -for management of pain and prevention of pathological fracture. The 2016 statement included recommendations that the use of these highly effective anti-resorptive medications be used in both pre-and post-menopausal women and, crucially, for the prevention of cancer treatment induced bone loss (CBITL) as well as prevention of bone metastases. It is particularly noteworthy that the recommendations mean a significant number of patients will receive anti-resorptive medication concomitantly with systemic chemotherapy.
This sea change of indications for antiresorptives will produce a large number of young patients who are at relatively high risk of developing MRONJ. Dr Tanna and co-authors correctly assert that education of primary care practitioners is important for effective management of patients who have taken anti-resorptive medications. We would like to suggest that communication and coordination between specialist oncology services, patients and primary care dentists is also of paramount importance in order to minimise adverse effects on this group of patients. Water fluoridation
There is no evidence
Sir, Drs Connett 1 and Osmunson 2 continue to bang their anti-fluoridation drum. Most recently they claim that fluoride is a neurotoxin with the implication that this will lead to neurological defects and reduced IQ in children. They often cite studies in rats and a few studies in China of children in rural areas exposed to high levels of fluoride naturally present in water which in some cases is further contaminated by arsenic. A study more relevant to community water fluoridation (CWF) was recently published by Broadbent et al. 3 They followed up almost 
Endorsed effectiveness
Sir, I note the recent letters to the editor from the Fluoride Action Network (FAN) purporting to show the dangers of water fluoridation. Orthodontics
Link with obesity
Sir, the excellent study done by Professor Martyn Cobourne and colleagues shows that obesity can affect the oral tissues and this can have effects on orthodontic tooth movement in adolescents. 1 A recent study has mentioned that the probability of meeting the global obesity target is almost impossible. 2 By 2025 global obesity prevalence in men and women will reach 18% and 21% respectively.
Adolescents and adults with an increased BMI may need a longer duration of treatment, with more appointments due to less co-operation and tooth movement. 3 Due to the increase in global obesity more adolescents and adults may require orthodontic treatment and this will add to the economic burden in both developed and developing countries. Fitness to practise
A question of reputation
Sir, we would like to respond to A. C. L. Holden's critique 1 of our recent paper. 2 We welcome debate on the issue of regulatory scope but we disagree with the characterisation of our position. We do believe behaviour outside the clinic can have a bearing upon professional practice. Our
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